Disseminated Talaromyces marneffei Infection With STAT3-Hyper-IgE Syndrome: A Case Series and Literature Review
- PMID: 37025100
- PMCID: PMC10072852
- DOI: 10.1093/ofid/ofac614
Disseminated Talaromyces marneffei Infection With STAT3-Hyper-IgE Syndrome: A Case Series and Literature Review
Abstract
Background: Little is known about the clinical characteristics of talaromycosis with hyper-immunoglobulin E syndrome (HIES).
Methods: We conducted a multicenter retrospective study, which included 7 hospitals from 2016 to 2022. Five consecutive cases of human immunodeficiency virus (HIV)-negative patients with systemic Talaromyces marneffei infections due to STAT3-HIES were identified. A systematic literature review of original articles published in English identified an additional 7 cases. Clinical characteristics and laboratory parameters were collected.
Results: Forty-two percent (5/12) of patients were young adults. The main symptoms of 10 patients were similar: fever (75%), cough (75%) and dyspnea (33%), but two patients mainly had gastrointestinal symptoms. Most patients had a history of infections since infancy. T marneffei was cultured from the bronchoalveolar lavage fluid (50%) and 25% of patients were next-generation sequencing positive. Eight patients had significantly elevated serum immunoglobulin E, increased B cells and decreased natural killer cells. There were ten different STAT3 mutations, three of which were reported for the first time in this study. Chest computed tomography examinations showed multiple exudations with cavities in the lungs. Voriconazole combined with thymosin was effective. Despite given antifungal agents, most had poor outcomes and the case fatality rate was as high as 25%.
Conclusions: STAT3-HIES is most likely a susceptibility factor for T marneffei infections among HIV-negative patients, which has a high case fatality rate. Increased awareness among clinicians is necessary to help in early diagnosis.
Keywords: STAT3 mutation; Talaromyces marneffei; hyper-IgE syndrome; immunodeficiency.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest.
Figures



Similar articles
-
Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases.BMC Infect Dis. 2021 Mar 20;21(1):287. doi: 10.1186/s12879-021-05978-z. BMC Infect Dis. 2021. PMID: 33743629 Free PMC article.
-
[Hyper-IgE syndrome in adults characterized by disseminated mixed infection: a case report and literature review].Zhonghua Jie He He Hu Xi Za Zhi. 2022 Jun 12;45(6):546-551. doi: 10.3760/cma.j.cn112147-20211102-00763. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35658378 Review. Chinese.
-
Characteristics of Endemic Mycoses Talaromyces marneffei Infection Associated with Inborn Errors of Immunity.J Clin Immunol. 2024 Sep 26;45(1):17. doi: 10.1007/s10875-024-01798-3. J Clin Immunol. 2024. PMID: 39325235
-
Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report.BMC Infect Dis. 2020 Jun 3;20(1):394. doi: 10.1186/s12879-020-05113-4. BMC Infect Dis. 2020. PMID: 32493232 Free PMC article.
-
Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report.Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620929225. doi: 10.1177/1753466620929225. Ther Adv Respir Dis. 2020. PMID: 32482141 Free PMC article.
Cited by
-
Ultrasound characterization of superficial lymph nodes in HIV patients with Talaromyces marneffei infection.Front Med (Lausanne). 2023 Dec 11;10:1243599. doi: 10.3389/fmed.2023.1243599. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38148912 Free PMC article.
-
Case report: Diagnosis of Talaromyces marneffei infection in an HIV-negative patient with septic shock and high-titer anti-interferon gamma autoantibodies by metagenomic next-generation sequencing.Front Cell Infect Microbiol. 2023 Jul 4;13:1163846. doi: 10.3389/fcimb.2023.1163846. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37469600 Free PMC article.
-
Endemic mycoses - are we making progress in management?Curr Opin Infect Dis. 2023 Dec 1;36(6):436-442. doi: 10.1097/QCO.0000000000000971. Epub 2023 Sep 26. Curr Opin Infect Dis. 2023. PMID: 37755392 Free PMC article. Review.
-
Human inborn errors of immunity underlying Talaromyces marneffei infections: a multicenter, retrospective cohort study.Front Immunol. 2025 Jan 22;16:1492000. doi: 10.3389/fimmu.2025.1492000. eCollection 2025. Front Immunol. 2025. PMID: 39911395 Free PMC article.
-
Hyper IgE Syndromes: Understanding, Management, and Future Perspectives: A Narrative Review.Health Sci Rep. 2025 Mar 19;8(3):e70497. doi: 10.1002/hsr2.70497. eCollection 2025 Mar. Health Sci Rep. 2025. PMID: 40114756 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous